Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion type Assertion NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_head.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion description "[Altogether, the data showed that (a) circulating testosterone may act with estrogenic effects downstream in the catabolic process present in the prostate, and (b) that the estrogenic effect of testosterone derivatives (ERbeta-dependent) results in the inhibition of cell migration, although it is apparently different from that linked to estradiol on the same receptor and may be protective against prostate cancer invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_provenance.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion evidence source_evidence_literature NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_provenance.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion SIO_000772 15958594 NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_provenance.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion wasDerivedFrom befree-2016 NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_provenance.
- NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_assertion wasGeneratedBy ECO_0000203 NP499744.RA2S3VwZlb7qGG2C-dd1Io9gd2U3SiFnFYDQj6m1Ci8F0130_provenance.